Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy.
Saved in:
| Title: | Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy. |
|---|---|
| Authors: | Maresca KP; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA. kevin.maresca@pfizer.com., Chen J; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Mathur D; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Regneron Pharmaceuticals, Tarrytown, NY, USA., Giddabasappa A; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Root A; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Generate Biomedicines, Inc, Cambridge, MA, USA., Narula J; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., King L; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Schaer D; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Golas J; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Regneron Pharmaceuticals, Tarrytown, NY, USA., Kobylarz K; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Rosfjord E; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA.; Black Diamond Therapeutics, New York, NY, USA., Keliher E; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Chen L; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Ram S; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Pickering EH; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Hardwick JS; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Rejto PA; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA., Hussein A; Invicro, A Konica Minolta Company, New Haven, USA., Ilovich O; Invicro, A Konica Minolta Company, New Haven, USA., Staton K; Evergreen Theragnostics, Jersey City, NJ, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wilson I; ImaginAb Inc., Inglewood, CA, USA., McCarthy TJ; Worldwide Research, Development & Medicine, Pfizer Inc, New York, USA. |
| Source: | Molecular imaging and biology [Mol Imaging Biol] 2021 Dec; Vol. 23 (6), pp. 941-951. Date of Electronic Publication: 2021 Jun 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101125610 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-2002 (Electronic) Linking ISSN: 15361632 NLM ISO Abbreviation: Mol Imaging Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
